直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Time Following Termination of Interference After RCE Reduces Patent Term Adjustment

October 14, 2019

Authored and Edited by Michael Liu Su; Kevin D. Rodkey; Elizabeth D. Ferrill

In Mayo Foundation for Medical Education and Research v. Iancu, No. 2018-2031 (Fed. Cir. Sept. 16, 2019), the Federal Circuit affirmed the district court’s decision that the USPTO properly concluded that Patent Term Adjustment (PTA) is reduced by the period after an interference concludes and the issuance of a notice of allowance, when the interference followed the filing of an Request for Continued Examination (RCE).

PTA can accrue when a patent application is pending for more than three years, but can also be reduced by “any time consumed by continued examination of the application requested by the applicant” and “any time consumed by a proceeding under [interference proceedings].” During prosecution of U.S. Patent Application No. 12/421,310, Mayo filed an RCE. After the RCE filing, the examiner declared an interference. After the interference concluded, the examiner issued an office action and subsequently issued a Notice of Allowance. Mayo’s timeline below summarizes the prosecution:

The USPTO deducted period 3 (04/23/14 to 11/03/14) in this chart from the PTA. Mayo disputed this. A district court confirmed the USPTO’s interpretation and Mayo appealed.

On appeal, the Federal Circuit affirmed the decision that the period after conclusion of an interference up to a notice of allowance is deducted from PTA when the interference followed an RCE filing. The court rejected Mayo’s argument that an interference is equivalent to a notice of allowance because claims must be “deemed allowable” to enter an interference. The court explained that the “[USPTO] regulations as a whole do not indicate that a declaration of an interference is tantamount to a Notice of Allowance.” The court also reasoned that the filing of an RCE is not limited to issues the applicant would like resolved, but also allows the examiner to issue new rejections before allowance.

The court held that “where an RCE has previously been filed, the time between termination of an interference and the date of mailing of the Notice of Allowance is ‘time consumed by continued examination’” that reduces PTA.

Judge Newman dissented, reasoning that Mayo had not requested further examination after the interference and that the majority’s result is contrary to patent policy.

Tags

patent term adjustment

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Kevin D. Rodkey
Partner
Atlanta, GA
+1 404 653 6484
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

Patent Litigation Europe 2027

January 18-20, 2027

Amsterdam

Panel Discussion

2026 Advanced Patent Law Institute

December 3-4, 2026

Stanford

Conference

Life Sciences Patent Network North America Fall 2026

November 2-3, 2026

San Francisco

Conference

4th Global Patent Litigation FORUM

October 29, 2026

Munich

Conference

2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada

October 14-16, 2026

New York

Lecture

Resolving Patent Suits Without Settlement Payments

September 3, 2026

Virtual

Articles

D. Mass. Patent Litigation Update, March 2026

D. Mass. Patent Litigation Update: July 2026

August 27, 2026

Webinar

A Year of Change for Post-Grant Patent Challenges: Key PTAB and CRU Developments, and Strategic Implications

August 19, 2026

Webinar

At the PTAB Blog

Squires Issues Precedential Decision Clarifying Obviousness-Type Double Patenting Rejections

August 17, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP